The Tick, the Table, and the Timeline: How a Tick Bite Rewrites Dinner
- Heather McSharry, PhD
- 10 hours ago
- 27 min read
Summary
A tick bite can change what happens at the dinner table months later.
In this episode of Infectious Dose, we explore alpha-gal syndrome (AGS), a tick-associated allergic condition that challenges many of the assumptions physicians and patients have about food allergies. Unlike most allergic reactions, symptoms often occur hours after eating and are triggered by a carbohydrate called galactose-α-1,3-galactose, or alpha-gal, found in mammalian meat and other animal-derived products.
We'll trace the scientific detective story that led researchers from unexplained reactions to a cancer drug to the discovery of a completely new allergic syndrome. Along the way, we'll examine the role of tick bites, the unique biology of tick saliva, why reactions are delayed, and what scientists still don't fully understand about the condition.
Part of our June series, Stories of Summer Rain, this episode explores how warm, wet environments shape the ecosystems around us—and how those ecosystems can unexpectedly shape our health.
Listen here or scroll down to read full episode.
Full Episode
The Allergy That Broke the Rules
A tick bite. A hamburger. And an emergency room visit six hours later. Those things don't sound connected. In fact, if I asked you to identify the culprit in that story, most people would probably choose the hamburger and assume food poisoning. And even though food allergies happen all the time...peanuts. Shellfish. Milk. Eggs. That would not be you first thought for this. Because with food allergies, you eat the food and your immune system overreacts immediately. Within minutes, you know something is wrong.
But what if the reaction didn't happen while you were eating?
Imagine this. You spend an afternoon hiking through the woods. A few weeks later, you're having dinner with your family. Maybe it's a steak. Maybe it's a burger. Maybe it's barbecue. You finish eating. You feel fine. You watch television. You brush your teeth. You go to bed.
And then around two o'clock in the morning, you wake up covered in hives. Your skin is on fire. Your stomach is cramping. Your lips feel swollen. Maybe you're struggling to breathe. It's terrifying. But it's also confusing. Because dinner was hours ago. The food seems unrelated. The timing makes no sense. Then it happens again. And again. And again. Each reaction seems random. Until eventually someone notices a pattern. And that pattern leads to one of the strangest allergic diseases modern medicine has ever discovered. A syndrome that can begin with a tick bite and end with a person becoming allergic to mammalian meat.
This is The Tick, the Table, and the Timeline: How a Tick Bite Rewrites Dinner.
And as we continue our June series, Stories of Summer Rain, we're moving from hurricanes and floodwaters to another consequence of warm, wet summers. Because summer rain doesn't just shape storms. It shapes ecosystems. It shapes where we spend our time outdoors. And it shapes our encounters with the ticks, mosquitoes, and other creatures that share those environments with us.
Today, we're focusing on one of the strangest examples of all.
And if you’ve ever had unexplained hives or stomach trouble hours after a meat-heavy dinner—especially if you live in tick country—this episode is for you. Because today we're talking about alpha-gal syndrome. Or AGS. A disease that has challenged some of our most basic assumptions about how allergies work. Nearly everything about it is strange.
The Set-Up
Most allergies follow a pretty familiar script. You eat something you're allergic to. Or you're exposed to pollen. Or a medication. Your immune system recognizes something it doesn't like. And within minutes symptoms begin. The timing is important. In fact, it's one of the things physicians rely on when trying to identify an allergic reaction. Cause. Then effect. Exposure. Then symptoms. The sequence is usually straightforward. Alpha-gal syndrome doesn't follow that script. It tears it up completely.
For starters, most food allergies are directed against proteins.
Proteins are large, complex molecules that the immune system is very good at recognizing. Peanut allergy? Protein. Milk allergy? Protein. Egg allergy? Protein.
Alpha-gal syndrome is different. The immune system isn't targeting a protein at all. It's targeting a carbohydrate. A sugar molecule. And while that may sound like a small distinction, it was a major surprise to allergy researchers. Because carbohydrates generally aren't the molecules we think about when we think about serious allergic disease. Yet here was a condition causing hives. Anaphylaxis. Severe gastrointestinal symptoms. Even life-threatening reactions. All linked to a sugar called galactose-alpha-1,3-galactose.
Thankfully, everyone realized pretty quickly that saying "galactose-alpha-1,3-galactose" over and over again was not sustainable. So the molecule became known simply as alpha-gal. And if the sugar itself wasn't strange enough, the timing was even stranger.
Patients were showing up in emergency rooms with hives, swelling, abdominal pain, and even anaphylaxis. But when physicians started asking what they had eaten or been exposed to right before symptoms began, the answers often didn't make sense.
Because the trigger meal wasn't immediately before symptoms. It was half a day earlier. And that delay would become one of the reasons alpha-gal syndrome remained hidden for so long. Many patients spent months. Sometimes years. Searching for explanations. Some were told it was stress. Others were diagnosed with chronic hives. Some were worked up for gastrointestinal disorders. And to be fair, the physicians were facing a mystery that violated many of the rules they had been taught. A food allergy that wasn't caused by a protein. A reaction that appeared hours after exposure. And a trigger that wasn't even obvious.
But the strangest part of the story was still waiting. Because the clue that would eventually solve this mystery wasn't discovered in a restaurant. Or a backyard barbecue. Or even an allergy clinic. It was discovered in a cancer treatment center. And it started with patients who were having severe reactions to a drug they had never received before.
The Cancer Drug Clue
In the early 2000s, physicians began using a relatively new cancer drug called cetuximab. Cetuximab is a monoclonal antibody—a laboratory-produced protein designed to target specific cancer cells. And, as with many biologic therapies, doctors knew allergic reactions were possible.
But there was a catch. Traditional allergic reactions require prior exposure. The immune system has to meet something once before it can become sensitized to it. The first encounter is usually uneventful. It's the second encounter that causes trouble. But some cetuximab patients were experiencing severe reactions during their very first infusion.
Not after months of treatment. Not after multiple doses. The very first one.
Some reactions were dramatic. Patients developed hives. Difficulty breathing. Dangerously low blood pressure. In some cases, full-blown anaphylaxis. And the pattern wasn't random. The reactions seemed to cluster in certain parts of the United States.
Especially in the Southeast. Researchers were puzzled. How could someone be allergic to a medication they had never received before? It meant that something inside cetuximab looked familiar to these patients' immune systems. But what?
Researchers began looking for antibodies. Specifically a type called IgE. The antibody most commonly associated with allergic reactions. And sure enough, many of these patients already had IgE antibodies that recognized something within the drug. Even before treatment began.
Which raised an even bigger question. If the antibodies existed before the drug exposure, what had created them? What had the immune system encountered earlier that looked enough like cetuximab to trigger a reaction?
Eventually scientists isolated the target. It wasn't the protein portion of the drug. It was a sugar attached to it. A carbohydrate. Galactose-alpha-1,3-galactose. Alpha-gal. And suddenly researchers found themselves staring at a molecule they hadn't expected to find at the center of a severe allergic reaction. Because alpha-gal isn't some rare laboratory chemical. It's actually remarkably common. In fact, it's found in most mammals. Cows. Pigs. Sheep. Deer. Rabbits. Whales. Pretty much every mammal you can think of. Except us.
Humans, along with other Old World primates, lost the ability to produce alpha-gal millions of years ago. Which means our immune systems recognize it as foreign. And that fact had already made alpha-gal interesting to immunologists. But now it was
Then another strange observation surfaced.Around the same time researchers were studying cetuximab reactions, allergists were seeing a different group of patients. People reporting allergic reactions after eating red meat. At first glance the cases didn't seem related. After all, what does a cancer drug have to do with a hamburger? But the stories were unusual. The patients weren't reacting immediately. The reactions often occurred several hours after eating. Many remembered episodes happening late at night after an evening meal. And when researchers tested them, they found something familiar. The same antibodies. IgE directed against alpha-gal. The same molecule implicated in the cetuximab mystery. Suddenly two unrelated medical puzzles snapped together like pieces of the same jigsaw puzzle. The cancer patients.The meat-allergy patients. The strange delayed reactions. The geographic clustering. The unusual carbohydrate target. They weren't separate stories at all. They were manifestations of the same underlying phenomenon. For the first time, scientists could see the outline of an entirely new allergic disease. A disease unlike anything they had encountered before.
But one critical question remained unanswered. Where were these antibodies coming from? What was exposing people to alpha-gal in the first place? Because most people eat mammalian meat their entire lives without becoming allergic to it. Something else had to be happening. Something that seemed to occur most often in exactly the same regions where these cases were appearing. And as researchers began looking at maps, interviewing patients, and comparing histories, a pattern started to emerge. Not a food. Not a medication. But ticks.
Following the Map
When you're trying to understand a disease, sometimes the epidemiological map you build can reveal patterns long before anyone understands the mechanism. They can point investigators toward answers. Or at least toward better questions. And in the case of alpha-gal syndrome, the map was becoming clear.
Researchers had figured out a lot but they still didn't know why some people were developing those antibodies in the first place. So they started looking for commonalities.
Who was getting sick? Where did they live? What exposures did they share? And something interesting began to emerge.
Many patients weren't just clustered in the same parts of the country. They were also reporting something else. Tick bites. Lots of tick bites. Now, at first glance, that may not sound especially remarkable. People who spend time outdoors get tick bites. And people who spend time outdoors also tend to hunt, hike, camp, fish, garden, and generally interact with the environment in ways that create all sorts of opportunities for exposure. Correlation isn't causation.
We like to say that. it means that just because two things happen together doesn't mean one caused the other. But the reports kept coming. Patient after patient. Tick bites. Sometimes recent. Sometimes months earlier. Sometimes accompanied by unusually large, itchy bite reactions that lingered for weeks.
And eventually researchers noticed something even more intriguing. The geography of alpha-gal syndrome looked suspiciously similar to the geography of a particular tick. The lone star tick. Now before we go any further, let's talk about this tick. Because despite its name, the lone star tick is anything but lonely. It's aggressive. It's abundant. And unlike some tick species that sit quietly on vegetation waiting for a host to brush past, lone star ticks are known for actively pursuing potential blood meals. Which is honestly a little unsettling. Most of us picture ticks as tiny hitchhikers. Lone star ticks can behave more like tiny stalkers. They're found across much of the southeastern and eastern United States, and their range has expanded considerably over the past several decades. If you've spent time outdoors in many parts of the South, Midwest, or Mid-Atlantic regions, there's a decent chance you've encountered one. Whether you realized it or not.
And the more researchers compared maps of lone star tick distribution with maps of alpha-gal syndrome cases, the harder it became to dismiss the overlap. It wasn't proof. But it was a clue. A very compelling clue.
Then another piece of evidence emerged. Patients often described being bitten not by a single tick, but by dozens. Or even hundreds. Particularly during the larval stage. Tiny immature ticks sometimes called seed ticks. Now if you've never encountered seed ticks, count yourself fortunate. Imagine brushing against vegetation and later discovering what looks like a sprinkling of pepper across your socks or skin. Except the pepper is alive. And hungry. And each one is looking for a blood meal.
Many alpha-gal patients remembered episodes exactly like that. Large numbers of bites.
Intense itching. And then, sometime later, the beginning of symptoms. Not everyone remembered a tick bite, of course. That's another challenge.Ticks are very good at going unnoticed.Some bites are forgotten.Some are never seen. Some occur months before symptoms develop.Which makes them easy to overlook. But collectively the pattern was becoming clear. The question was no longer whether ticks were involved.
The question was how. What exactly was happening during a tick bite that could persuade the immune system to develop an allergy to mammalian meat? To answer that, scientists began dissecting ticks. Literally. They examined salivary glands. Analyzed saliva. Looked for molecules that might connect the dots. And what they found was remarkable. Evidence that alpha-gal itself—or molecules carrying alpha-gal—could be found within tick tissues and saliva.
Suddenly the theory began to look much stronger. Because now there was a plausible pathway. A tick attaches. It feeds. Its saliva enters the skin. And along with that saliva comes a complex mixture of molecules capable of manipulating the immune system.
Remember, tick saliva isn't just there to lubricate a bite. It's a sophisticated biological toolkit. Ticks need to feed for days without being noticed. So their saliva contains compounds that reduce pain, interfere with clotting, alter inflammation, and help them remain attached to a host. In many ways, a feeding tick is conducting a biochemical negotiation with the immune system.
Another question researchers have spent years trying to answer is: where does the alpha-gal actually come from?
At first glance, the answer seems obvious. Ticks feed on mammals such as deer, rabbits, and cattle, all of which naturally produce alpha-gal. So one early idea was that ticks were simply carrying alpha-gal from one host to another.
But the story appears to be more complicated than that.
Today, many researchers think ticks may be acting less like contaminated syringes and more like tiny biological factories. Evidence suggests ticks can take alpha-gal-containing molecules, process them, attach them to their own proteins or lipids, and then secrete those molecules in saliva.
There is also growing evidence that ticks may be capable of producing or assembling alpha-gal-containing structures themselves, possibly with help from microbes that live within the tick. The details are still being worked out, but the field has largely moved beyond the idea that ticks are simply injecting leftover blood from a previous meal.
In other words, the alpha-gal in tick saliva appears to be an active biological product, not just contamination.
And that raises another interesting question. Mosquitoes feed on mammals too. So why don't mosquitoes appear to cause alpha-gal syndrome? The answer may provide some of the strongest clues about what makes ticks different. For one thing, mosquitoes and ticks feed in very different ways. A mosquito lands, feeds for a few minutes, and leaves. A tick may remain attached for days. But the bigger difference is saliva.
Tick saliva is remarkably complex. It contains compounds that suppress inflammation, interfere with blood clotting, alter immune responses, and help the tick remain attached to its host. Some researchers believe those immune-modifying effects may act almost like an adjuvant, pushing the immune system toward the production of alpha-gal-specific IgE antibodies.
Mosquitoes simply don't create the same prolonged immune environment.
And that's one reason alpha-gal syndrome has become such an interesting scientific puzzle. The evidence increasingly suggests that alpha-gal alone may not be enough. The tick may be providing both the target and the immune signals needed to transform that target into an allergy. Which means understanding why mosquitoes don't cause alpha-gal syndrome may ultimately help researchers understand exactly how ticks do.
And somewhere within that interaction, scientists believe some people's immune systems are being pushed down a very unusual path. Toward the production of IgE antibodies against alpha-gal. But that raises yet another question. If alpha-gal exists in mammals all around us, why doesn't everyone develop this allergy? Why do some people get bitten by ticks for decades and never experience a problem? While others develop a life-changing allergy after what seems like only a handful of bites?
The truth is, we don't completely know. And I think that's important to say. The connection between tick bites and alpha-gal syndrome is now supported by a substantial body of evidence. But there are still unanswered questions. Why some people become sensitized. Why others don't. Why reactions vary so dramatically from person to person. Those pieces of the puzzle are still being assembled.
But by this point, researchers had enough evidence to identify the prime suspect. The tick wasn't just associated with alpha-gal syndrome. For most patients studied so far, the tick bite appears to be the main event that starts the chain reaction. A bite in the woods. An immune system taking a wrong turn. And months later, an allergic reaction at the dinner table. And to be clear, the association with ticks has been best demonstrated for specific ticks (e.g., lone star tick and a few others), but not all tick‑alpha‑gal relationships have been fully mapped globally.
But there's still one piece of this story that doesn't make sense. Even if a tick bite creates the allergy, why does the reaction wait hours to appear? Why doesn't it happen the moment someone takes the first bite of a steak? To answer that, we need to follow alpha-gal on a journey through the digestive system, into the bloodstream, and ultimately to the immune cells waiting for it. And that journey turns out to be the key to one of the strangest features of this entire disease.
Why The Symptoms Arrive At Midnight
Imagine you've just eaten a cheeseburger. Or a steak. Or maybe a plate of barbecue. The meal enters your stomach. Digestion begins. Proteins are broken apart. Fats are processed. Nutrients start moving through the digestive tract. And somewhere in that meal is alpha-gal. Not floating around on its own, though. It's attached to molecules derived from mammalian tissues.
Now here's where things get interesting. Researchers spent years trying to understand why alpha-gal reactions happen hours later instead of minutes later. And today, the leading explanation involves something that most of us rarely think about. And that's fat absorption. Because unlike many food allergens, alpha-gal appears to hitch a ride through the body in a particular way that takes time.
Let's zoom in. After food leaves the stomach, it enters the small intestine. This is where much of the body's nutrient absorption takes place. And fats present a unique challenge. Unlike many nutrients that can move directly into the bloodstream, dietary fats have to be packaged for transport. Think of it like preparing cargo for shipping. The body can't simply dump large amounts of fat directly into circulation. Instead, specialized cells in the intestine wrap fats into tiny transport particles. These particles are called chylomicrons. And while "chylomicron" sounds like either a Transformer or a minor villain from a Marvel movie—it's actually a completely normal part of human physiology. Every time you eat a fatty meal, your body makes them. Thousands upon thousands of them.
Tiny biological delivery trucks moving fat through the body. And scientists now believe alpha-gal may be riding inside those trucks. If that theory is correct—and the evidence supporting it has become increasingly compelling—it helps explain one of the most puzzling features of alpha-gal syndrome.
Because chylomicrons don't enter the bloodstream immediately. First, they travel through the lymphatic system. A vast network of vessels that runs alongside the circulatory system. Only later do they empty into the bloodstream. And that entire process takes time. Hours, not minutes. Which means the immune system may not encounter significant amounts of alpha-gal until long after the meal is finished. Long after the dishes are washed. Long after the evening news is over. Long after someone has gone to bed. Suddenly that strange delay starts making sense. The allergen wasn't late. It was still in transit.
Now, before we go any further, I want to pause for a moment and talk about scientific uncertainty. Because this is one of those places where it's important to separate what we know from what we think we know. The evidence supporting this lipid transport—or glycolipid—hypothesis is strong. Researchers have demonstrated that alpha-gal associated with lipids can move across intestinal cells in ways that make it available to the immune system. And the timing matches what clinicians observe in patients. But science is rarely as neat as we'd like. There are still unanswered questions. Now there are some data that alpha‑gal is also carried on protein‑associated structures, and the relative contribution of those is still being worked out. Others are trying to understand why reactions vary so dramatically from one person to another. So while the chylomicron model is currently the leading explanation, the story is still evolving. And that's okay. Science isn't weakened by uncertainty. Science advances by acknowledging it.
But regardless of the exact details, the end result is the same. Hours after the meal, alpha-gal finally arrives in circulation. And waiting for it are antibodies created months earlier during that tick bite. Specifically, IgE antibodies. And once IgE antibodies are produced, they don't simply float around aimlessly. They attach themselves to immune cells called mast cells and basophils. Think of these cells as biological tripwires. They're loaded with chemical mediators. Histamine. Leukotrienes. Other inflammatory molecules. And when enough IgE molecules recognize their target at the same time, those cells activate. The tripwire is triggered. And suddenly a cascade begins. Histamine is released. Blood vessels become leaky. Tissues swell. Nerves become irritated. Smooth muscles contract. The symptoms of an allergic reaction begin to unfold. Hives. Itching. Swelling. Abdominal pain. Diarrhea. Vomiting. Difficulty breathing. In severe cases, anaphylaxis. The exact symptoms vary from person to person. But the underlying mechanism is remarkably similar. The immune system sees danger where none exists. And responds with overwhelming force. But even after researchers understood much of this mechanism, patients were still facing another problem. Recognition. Because understanding a disease in the laboratory is one thing. Diagnosing it in the real world is something else entirely.
When Diagnosis Gets Messy
By the time many patients finally receive a diagnosis, they've often spent months—or years—trying to solve the mystery on their own. Because alpha-gal can look different in different patients, many with the syndrome spend time being evaluated for other conditions first. like irritable bowel syndrome. Food intolerance. Gallbladder disease. Acid reflux. Or inflammatory bowel disease. And in fairness, those are often reasonable possibilities. The symptoms overlap, which is part of the challenge.
And then there's another problem. And that's human memory. Most of us aren't particularly good at reconstructing what we ate six hours ago. Especially if the reaction occurs in the middle of the night.
But to recognize the pattern, you have to think backward. Hours backward. Sometimes days. Sometimes weeks. You have to connect a midnight reaction to a dinner you barely remember. And that's not an intuitive thing for most people—or most clinicians—to do.
But with infectious disease, exposure may occur days or weeks before symptoms appear. With alpha-gal syndrome, the delay is shorter. But the principle is remarkably similar. The event causing the problem isn't always the most recent event. And if you don't know that, the diagnosis can remain hidden in plain sight.
Eventually, though, someone asks the right question. Someone notices the pattern.
Someone considers alpha-gal syndrome. And that's where laboratory testing enters the story. Now, when most people hear the phrase "allergy test," they picture skin testing.
Tiny drops placed on the skin and small pin pricks. Waiting to see whether a raised bump appears. And while skin testing plays an important role in allergy medicine, alpha-gal syndrome has forced allergists to be somewhat cautious. Because traditional skin testing with commercial meat extracts doesn't always perform as well as you'd hope.
False negatives happen. Sometimes frequently. Meaning a patient can have alpha-gal syndrome and still have a skin test that appears reassuring. Which is one reason blood testing became so important. Specifically, a blood test that looks for IgE antibodies directed against alpha-gal.
But here's where I want to be careful. Because this is one of the most important misconceptions surrounding alpha-gal syndrome. A positive test is not the same thing as a diagnosis. That distinction matters. A lot. Because antibodies tell us the immune system has seen something. They don't automatically tell us whether that person becomes sick when exposed. Think about it this way. Evidence of exposure is not always evidence of disease. Those are related concepts. But they aren't identical. In regions where tick exposure is common, researchers have found people with alpha-gal antibodies who never develop symptoms. Their immune systems were sensitized. But they don't have clinically significant alpha-gal syndrome. So when allergists evaluate a patient, they're not looking only at the blood test.
They're looking at the entire story. The symptoms. The timing. The foods involved. The exposure history. The tick bites. The pattern. Because alpha-gal syndrome is one of those conditions where context is everything. A positive laboratory result without a compatible history can be misleading.
And a compatible history without the right testing can leave important questions unanswered. The diagnosis emerges when the pieces fit together. Not when a single test result appears. Now occasionally, even after testing, uncertainty remains. Maybe the history isn't entirely clear. Maybe the symptoms are atypical. Maybe multiple conditions are occurring at the same time. And in those situations, allergists sometimes turn to what is essentially the final exam of food allergy diagnosis. An oral food challenge. Which is exactly what it sounds like. A patient consumes the suspected food under close medical supervision while clinicians monitor for symptoms.
For many food allergies, that's stressful enough. For alpha-gal syndrome, it's particularly challenging. Because remember: The reaction doesn't happen immediately. The patient may need to be observed for hours. And if a reaction occurs, it can be severe. Which means food challenges are generally reserved for carefully selected situations and performed by specialists equipped to manage serious allergic reactions. They're valuable. But they're not casual.
What strikes me most about alpha-gal syndrome is that the diagnosis often depends less on advanced technology than on careful observation. And for many patients, finally having an explanation can be almost as important as the diagnosis itself. Because now they know what they're fighting. But diagnosis is only the beginning. The next challenge is figuring out how to live with a disease that can change what you eat, where you go, what medications you take, and even how you think about spending time outdoors. And perhaps surprisingly, the future isn't always as bleak as many patients fear.
Living With It
Well, the good news is that alpha-gal syndrome isn't a one-size-fits-all disease. The frustrating news is that alpha-gal syndrome isn't a one-size-fits-all disease. The same thing that makes management possible can also make it complicated. Because different patients react to different things. And they react with different levels of severity.
Let's start with the biggest misconception. Alpha-gal syndrome is often described as a red meat allergy. And that's not entirely wrong. But it's not the whole story either. The problem isn't actually "red meat." The problem is alpha-gal. And alpha-gal can show up in a variety of mammalian products including beef, pork, lamb, venison, organ meats, and certain animal-derived ingredients like gelatin. And sometimes medications. Sometimes products people never thought to question. Which means the learning curve after diagnosis can be steep.
At the same time, it's important not to overstate the restrictions. One of the most reassuring facts about alpha-gal syndrome is that reactions vary considerably.
For example, many patients tolerate dairy products without significant problems.
Others don't. Some react to gelatin-containing products. Others never do. Some have reactions primarily after eating fatty mammalian meats. Others appear more sensitive.
The details differ. Which is why management often becomes highly individualized.
But...one of the most important conversations patients have with their allergist involves emergency preparedness. Because while many reactions are mild or moderate, alpha-gal syndrome can cause anaphylaxis, which is not something to take lightly. For that reason, many patients are advised to carry epinephrine in case they experience a severe allergic reaction. Preparedness matters. You hope you'll never need the plan, but you make the plan anyway.
But perhaps the most important recommendation for people with alpha-gal syndrome has nothing to do with food. It's avoiding future tick bites. Researchers have observed that repeated tick bites can boost alpha-gal-specific antibody levels in some patients. In other words, additional tick exposures may reinforce the very immune response we're trying to calm down. So tick prevention isn't just about avoiding new diseases. It's also part of managing the disease you already have.
One question you might be wondering is whether people who already have alpha-gal syndrome react directly to tick bites. And the answer is: sometimes, yes.
Many patients with AGS report unusually large local reactions to subsequent tick bites—significant swelling, intense itching, or persistent inflammation around the bite site. Some develop hives, and there are published reports of more widespread allergic reactions associated with tick bites themselves. Rarely, severe systemic reactions have been reported. Interestingly, those reactions appear to be much less common than reactions triggered by mammalian meat.
Scientists aren't entirely sure why, but one possibility is simply dose. A tick may introduce enough alpha-gal and immune-stimulating molecules to reinforce or boost the allergic response without delivering the same amount of alpha-gal a person might encounter in a steak dinner. That's one reason researchers suspect repeated tick exposures may be important in both the development and persistence of the syndrome.
And fortunately, many of the recommendations for tick prevention are familiar, like use EPA-registered repellents. Consider permethrin-treated clothing. Perform tick checks after spending time outdoors. Pay attention to pets that may carry ticks indoors. Remove attached ticks promptly. They are simple measures but important ones. When I first moved to Galveston for grad school, I rented an old raised house. The underside wasn't insulated—just wooden floorboards over a dirt-floored storage area. The house had plenty of gaps between the boards, and I kept finding ticks. Not on my dog—she was on tick prevention—but on me. Sometimes I'd sweep the floor and find several ticks in the dustpan.
Eventually I mentioned it to Stephen Higgs, a tick expert and one of my professors. He explained that ticks can survive for surprisingly long periods in sheltered environments, waiting for the vibration, warmth, and carbon dioxide cues that signal a potential blood meal. Then he asked me to do something unexpected: the next time I swept up a few ticks, bring them to him. Apparently maintaining tick colonies for research isn't always easy. So I did. Somewhere in a laboratory colony, there may still be descendants of the ticks that used to crawl through the cracks in my living room floor. Which is either a fun scientific contribution or the beginning of a horror movie.
OK, back to it. So, this is where the story takes a somewhat unexpected turn.
Because unlike many allergies, alpha-gal syndrome doesn't always remain static.
For some patients, antibody levels decline over time. Especially if they successfully avoid additional tick bites. Now, that doesn't mean everyone recovers. It doesn't mean people should start experimenting with foods on their own. And it certainly doesn't mean there is a guaranteed timeline. There isn't.
But for some patients, the future may look different than the present. In some cases, people who avoid further tick exposure eventually find that their sensitivity decreases.
A subset are able to reintroduce certain foods under medical supervision. And of course, any reintroduction should be done with an allergist, given risk of severe reactions.
But the idea is an important nuance. The story isn't always one of permanent worsening. Sometimes it's one of gradual improvement. Sometimes it's a story of adaptation. And sometimes it's a reminder that the immune system is dynamic. Not fixed.
Of course, there are still challenges. Restaurant menus don't usually come with alpha-gal warnings. Medication ingredients can be difficult to interpret. Travel requires planning. Outdoor activities may feel different than they once did. And there's an emotional component as well. Food is social. Food is cultural. Food is family traditions. It's holidays. Cookouts. Birthday dinners. Vacations. Changing what you eat isn't simply a nutritional adjustment. It's often a lifestyle adjustment. And I think that's something that can be easy to underestimate if you've never experienced it.
But perhaps the most important lesson from patients living with alpha-gal syndrome is that adaptation is possible. Not easy. Not immediate. But possible.
And yet, despite everything we've discussed so far, alpha-gal syndrome remains a surprisingly misunderstood condition. Because whenever science encounters something genuinely strange, misinformation is rarely far behind. Which brings us to the final challenge in the alpha-gal story. Not the biology or diagnosis. But the myths.
The Conspiracy Theories
Let's start with perhaps the simplest misconception. The idea that alpha-gal syndrome isn't real. That it's psychological. Stress-related. A trend. Or somehow exaggerated. This one is actually fairly easy to address. Because alpha-gal syndrome isn't supported by anecdotes alone. It's supported by immunology. Researchers can measure alpha-gal-specific IgE antibodies. They can observe allergic reactions. They can identify the same immune mechanisms involved in other allergic diseases. The symptoms are real. The antibodies are real. The reactions are real. And the variability is real too. But variability is not the same thing as unreality. Many diseases present differently in different people. That doesn't make them imaginary.
Then there are the vaccine claims. And here it's important to be precise. Some online discussions claim vaccines cause alpha-gal syndrome. The evidence does not support that conclusion. The strongest evidence points overwhelmingly toward tick bites as the primary route of sensitization. That's the explanation supported by epidemiology, patient histories, immunology, geography, and laboratory studies.
Now, there is a separate and much narrower question involving people who already have alpha-gal syndrome. Stay with me. Certain medical products may contain animal-derived ingredients. Some vaccines historically contained ingredients such as gelatin derived from mammalian sources. In rare situations, those ingredients may be relevant to individual patients. Like we've seen cases where someone with a gelatin allergy had an allergic reaction to a vaccine that contained gelatin as a stabilizer. But that is a completely different question than whether vaccines cause alpha-gal syndrome in the first place. They do not. And conflating them creates more confusion than clarity.
Then we arrive at perhaps the most elaborate theory of all. The claim that lone star ticks were engineered or intentionally released by the government. Sometimes the story involves biological weapons research. Sometimes it involves attempts to damage the beef industry. Sometimes it involves efforts to reduce meat consumption. And often, these claims become connected to another long-running story involving Plum Island.
Now, if you're unfamiliar with Plum Island, it's a federal research facility located off the coast of New York that historically conducted research on animal diseases. And I am planning an episode on it. I keep saying that, I guess I should actually do it. Anyway, over the years, it has become the focus of numerous conspiracy theories involving escaped pathogens, escaped ticks, biological weapons, and secret experiments.
The problem is that none of those claims provide convincing evidence for alpha-gal syndrome. And perhaps more importantly, none of them are necessary to explain what we're observing.
For example, the engineered-tick theory isn't supported by the evidence. For a couple of reasons. First, the Lone Star tick wasn't invented or created at Plum Island, neither was any other tick. We have scientific descriptions of tick species, including the lone star tick, dating back centuries before Plum Island existed. Also, the engineered theory requires us to ignore something we've already seen happen repeatedly throughout history. And that is that ecology changes. Species expand their ranges. Human behavior changes. Climate changes. Land use changes. And disease patterns change with them. We've seen mosquitoes move into new regions. We've seen ticks expand into new regions. We've seen pathogens emerge in places they weren't previously recognized. None of that requires a conspiracy. It requires ecology. And ecology is often more powerful than people realize. The natural world doesn't need help becoming complicated. It manages that quite well on its own.
Look, conspiracy theories in general often emerge when people encounter a real mystery. And alpha-gal syndrome absolutely was a mystery. Scientists didn't understand it initially. Patients struggled to get diagnosed. Researchers spent years piecing together the mechanism. There were genuine unanswered questions. But unanswered questions are not evidence of secret answers. They're simply unanswered questions. And over time, many of those questions have been addressed through the normal scientific process. Researchers mapped cases, studied patients, analyzed tick saliva, investigated immune responses, and tested hypotheses. They discarded some ideas and refined others. And gradually built a coherent explanation. Not a perfect explanation. There are still things we don't know. But a scientifically grounded explanation that will no doubt evolve as we collect more data.
In some ways, alpha-gal syndrome offers a useful reminder about scientific uncertainty.
Science doesn't claim certainty where certainty doesn't exist. It updates. It refines. It changes as evidence accumulates. And that's exactly what happened here. Researchers followed the evidence. From a cancer drug to a sugar molecule to tick bites to immune mechanisms to a disease that had been hiding in plain sight.
And while not every question has been answered, the overall picture is remarkably consistent. The evidence points toward a tick-associated allergic disease. Not a secret government program. Not a plot against ranchers. Not an attempt to eliminate hamburgers. Just a genuinely unusual interaction between ecology, immunology, and human biology. And look if someone was out to get rid of burgers I would be the first to call them out and protest.
But honestly, the truth is far more interesting, here. Because unlike a conspiracy theory, it's real. It's the perfect storm of a tiny, disgusting parasite. A misplaced immune response. A delayed allergic reaction. And a scientific mystery that took years to unravel. I mean that's already an extraordinary story. No secret laboratory required.
Check out the companion blog post for all citations and further reading suggestions at infectiousdose.com.
Alpha-gal syndrome isn't just a story about ticks. Or allergies. It's also a reminder that our health is connected to the environments we move through every day. Sometimes a summer rain story looks like a hurricane. Sometimes it looks like a mosquito. And sometimes it looks like a tick bite that quietly rewrites our summer BBQ stories.
And next week, we're chasing the smell of rain. We'll explore petrichor, geosmin, thunderstorms, and the science behind one of the most beloved scents in nature. But if I'm being honest, this episode is also a bit of a love letter to summer rain. The kind that rattles against the windows. The kind that cools the air after a long hot day. The kind that makes you stop whatever you're doing and listen.
So if you need a break from the headlines for an hour, I hope you'll join me.
And if there are significant developments in the Ebola outbreak before then, I'll release a separate Outbreak Watch update as well. Either way, Outbreak Watch updates appear every week in Field Notes, the free Infectious Dose newsletter. So if you'd like to keep up with important outbreak developments between episodes, you can subscribe here.
Until next time, stay healthy, stay informed, and spread knowledge not diseases. Thanks for checking out Infectious Dose.
Annotated References & Further Reading
The papers below were selected because they represent either landmark discoveries, major reviews, or important clinical guidance related to alpha-gal syndrome (AGS). If you're new to the topic, the review articles are the best place to start. If you're interested in how scientists solved the mystery, the landmark discovery papers tell that story.
Landmark Discovery Papers
Chung CH, et al. (2008)
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose New England Journal of Medicine https://www.nejm.org/doi/full/10.1056/NEJMoa074943
➡This is the paper that started it all. Researchers investigating severe allergic reactions to the cancer drug cetuximab discovered that some patients already had IgE antibodies against a sugar called alpha-gal before ever receiving the drug. This unexpected finding launched the scientific investigation that eventually led to the discovery of alpha-gal syndrome.
Commins SP, et al. (2009)
Delayed Anaphylaxis, Angioedema, or Urticaria After Consumption of Red Meat in Patients with IgE Antibodies Specific for Galactose-α-1,3-Galactose Journal of Allergy and Clinical Immunology https://www.jacionline.org/article/S0091-6749(08)01931-3/fulltext
➡This landmark study formally connected alpha-gal antibodies to delayed allergic reactions after eating mammalian meat. It established AGS as a distinct allergic condition and helped explain why patients were experiencing symptoms hours after dinner instead of immediately after eating.
Commins SP, James HR, Kelly LA, et al. (2011)
The Relevance of Tick Bites to the Production of IgE Antibodies to the Mammalian Oligosaccharide Galactose-α-1,3-Galactose Journal of Allergy and Clinical Immunology
➡One of the most important papers in the field. This study demonstrated the relationship between tick bites and the development of alpha-gal-specific IgE antibodies, helping establish ticks as the key trigger for sensitization.
Tick Biology & Mechanism
Crispell G, et al. (2019)
Discovery of Alpha-Gal-Containing Antigens in North American Tick Species Believed to Induce Red Meat Allergy Frontiers in Immunology https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01056/full
➡This study identified alpha-gal-containing molecules within tick tissues and saliva, providing important biological evidence explaining how tick bites may trigger the immune response that leads to AGS.
Platts-Mills TAE, et al (2020)
Diagnosis and Management of Patients with the α-Gal Syndrome Journal of Allergy and Clinical Immunology: In Practice (Paywalled so PDF below)
➡Written by researchers who played central roles in the discovery and study of AGS, this review explains the immunology, delayed reactions, diagnosis, and management of the syndrome.
Clinical Diagnosis & Management
Commins SP (2020)
Diagnosis & Management of Alpha-Gal Syndrome: Lessons from 2,500 Patients Journal of Allergy and Clinical Immunology: In Practice (Paywalled so PDF below)
➡One of the most practical clinical reviews available. Drawing on extensive patient experience, it discusses common symptoms, diagnostic challenges, management strategies, prognosis, and the realities of living with AGS.
Epidemiology & Public Health
Thompson JM, et al. (2023)
Geographic Distribution of Suspected Alpha-Gal Syndrome Cases — United States, 2017–2022 MMWR https://www.cdc.gov/mmwr/volumes/72/wr/mm7230a2.htm
➡This CDC analysis estimated more than 90,000 suspected AGS cases in the United States and demonstrated how closely the syndrome tracks with the distribution of ticks in many regions of the country.
Kersh GJ, et al. (2023)
Tick Bite as a Risk Factor for Alpha-Gal-Specific Immunoglobulin E Antibodies and Development of Alpha-Gal Syndrome Annals of Allergy, Asthma & Immunology
➡A modern CDC case-control study providing strong epidemiologic evidence linking tick exposure to the development of alpha-gal antibodies and AGS.
Special Topics
Stone CA Jr., et al. (2017)
Anaphylaxis After Vaccination in a Pediatric Patient: Further Implicating Alpha-Gal Allergy Journal of Allergy and Clinical Immunology: In Practice (Paywalled so PDF below)
➡This paper is frequently cited in discussions about alpha-gal and medical products. It explores how certain mammalian-derived ingredients may be relevant for some AGS patients while illustrating why individualized medical guidance is important.
Additional Patient Resources
Yale Medicine: Alpha-Gal Syndrome
➡A patient-friendly overview of symptoms, diagnosis, treatment, and long-term management written for a general audience.
Cleveland Clinic: Alpha-Gal Syndrome https://my.clevelandclinic.org/health/diseases/24493-alpha-gal-syndrome
➡An accessible introduction to AGS with practical explanations and common questions patients often ask after diagnosis.
CDC: Alpha-Gal Syndrome Resources
➡Provides current information on symptoms, prevention, tick-bite avoidance, diagnosis, and public health surveillance.